top of page
with out wording_edited.png


Canada lacks ‘political will’ to waive COVID-19 vaccine patents, Bolivian minister says


6 October 2021

Would Waiving COVID-19 Vaccines Patents Save Lives?

18 May 2021

Canadian Company Requests for Licence to Manufacture J&J’s COVID-19 Vaccine, May Stir Up Patent War

12 March 2021

COVID-19 Vaccine and Western Pharmaceutical Firms: A Complex Global Picture
BRE Review

16 June 2021

Canada’s Political Choices Restrain Vaccine Equity: The Bolivia-Biolyse Case 

26 September 2021

Waiving Vaccine Patents Won’t Help Inoculate Poorer Nations
Washington Post

15 March 2021

Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine

Health Policy Watch

11 November 2021

Global South Politicians to Lead Vaccine Summit After G-7 'fiasco'

18 June 2021

NDP Urges Canadian Government to Support COVID Vaccine Patent Waiver at the WTO

14 Oct. 2021

COVID Vaccine Makers Reject Offers to Expand Production Despite Citing Scale-Up as IP Waiver Alternative

FDA News

18 May 2021

Seven Reasons the EU is Wrong to Oppose the TRIPS Waiver

Human Rights Watch

03 June 2021

Big vaccine makers reject offers to help produce more jabs

Several drugmakers say they have capacity to help produce millions of doses.


14 May 2021

What Would It Take to Vaccinate the World Against Covid?

The New York Times

15 October 2021

How to Manufacture Covid-19 Vaccines Without the Help of J&J, Pfizer or Moderna? Biolyse Sees the Difficulties Up Close

Endpoint News

17 May 2021

Canadian Firm Scathing On Obstacles To Compulsory Licensing

Biolyse Is Determined To Manufacture J&J’s COVID-19 Vaccine

Pink Sheet

27 May  2021

Canadian Company Pursues Compulsory License to Distribute Covid-19 Vaccine to Low-Income Countries


29 March 2021

St. Catharines Pharmaceutical Company Wants to Help with Global COVID-19 Vaccine Rollout

The Globe & Mail

11 May 2021

Canadian Company Wins COVID-19 Vaccine Deal with Bolivia – and WTO Support

The Globe & mail

11 May 2021

Bolivia Signs J&J Vaccine Deal with a Twist - It Needs WTO Patent Waiver


11 May 2021

Bolivia Seeks to Import COVID-19 Vaccines from Biolyse, if Canada Grants Them a Compulsory License


11 May 2021

This Small Canadian Drugmaker Wants to Make J&J Vaccines for Poor Nations. It Needs More Than a Patent Waiver


06 May 2021

With One Simple Decision, the Canadian Government Can Save Lives


28 September 2021

Factory Owners Around the World Stand Ready to Manufacture COVID-19 Vaccines

The Intercept

29 April 2021

St. Catharines Company Biolyse Strikes COVID-19 Vaccine Deal with Bolivia

Niagara This Week

11 May 2021

Brock University Researchers, Biolyse Pharma Working to Enhance Effectiveness of Quercetin

St. Catharines Standard

25 November 2020

Bolivia and Biolyse Sign Landmark Agreement for Export of COVID-19 Vaccines


12 May 2021

Canadian Firm Seeks Mandatory Licence to Produce COVID-19 Vaccines for Poorer Countries

The Globe & Mail

09 April 2021

Bolivia Could Unlock New Access to Life-Saving COVID-19 Vaccines — But Needs Canada to Grant a License

02 August 2021

Biolyse Suggests Health Canada Lacks Urgency Over Its Task to Produce COVID-19 Vaccines for Export

Global News

Posted April 8, 2021 10:19 am

Updated April 8, 2021 3:57 pm

Bolivia and Biolyse Sign Landmark Agreement for Export of COVID-19 Vaccines


May 12, 2021, 6:32 AM EDT

On the Morals of Giants: How Patents Encourage Innovation During COVID-19

Monday, June 28, 2021 @ 1:14 PM

Bolivia wants to import COVID-19 vaccines from Canada | Coronavirus

News in 24

9 June 2021

Canadian Company to J&J: License, or Else. . . .


March 15, 2021


A Canadian company challenges vaccine rules to increase access

April 1, 2021 

Watch the Global Vaccine Inequity: COVID-19 and Canada’s Access to Medicines Regime Webinar + with highlights

29 Jun 2021

The world is Desperate for More Covid Vaccines – Patents Shouldn’t Get in the Way

The Guardian

24 April 2021

Bolivia Pursues Compulsory License to Get Vaccine


11 May 2021

COVID-19 Vaccine Patent Waiver Will Not Be Enough to Bridge Supply Gap: WTO


20 May 2021

COVID-19 Vaccine Patent Waiver Will Not Be Enough to Bridge Supply Gap: WTO


20 May 2021

Bolivia: Patients’ or Patents’ Rights in the Times of the Pandemic?

29 July 2021



11 May  2021

Update on the Proposed TRIPS Waiver at the WTO: Where is it Headed, and What to Expect?


8 June 2021

Inside the Campaign to Force Big Pharma to Make COVID Vaccines Available to Everyone

Vice World News

8 June 2021 

Explained: Why US statement on waiving vaccine patents is important in fight against Covid-19

The Indian Express

11 June 2021 

bottom of page